Skip to main content
AmigoFish

Episode 535 - Uromigos Live 2026 – MIBC: The Evolution of Antibody Drug Conjugates (ADCs) in Bladder Cancer

From The Uromigos · · 43 min

This plays from the publisher's own server. We do not host a copy.

Open at the source

Not rated yet

Description

ADCs have become a mainstay of systemic therapy in bladder cancer. Where are we headed next? The panel discusses issues around target, payload and sequencing.

Back to The Uromigos · Report a problem